Alnylam Pharmaceuticals | Créanciers Commerciaux



Trade Creditors Changement Date
Acadia Pharmaceuticals USD 18.1M 1.9M 2025-03
Agios Pharmaceuticals USD 13.73M 2.92M 2025-03
Alnylam Pharmaceuticals USD 97.4M 8.98M 2025-03
Amgen USD 2.41B 498M 2025-03
Arrowhead Research USD 9.98M 4.48M 2025-03
BioMarin Pharmaceutical 235.4M 480.26M 2024-12
Incyte USD 195.54M 1.93M 2025-03
Ionis Pharmaceuticals USD 17.46M 25.51M 2025-03
Moderna USD 226M 179M 2025-03
Neurocrine Biosciences 110M 282.7M 2024-12
Novartis USD 4.57B 485M 2024-12
PTC Therapeutics USD 15.15M 2.12M 2025-03
Regeneron Pharmaceuticals USD 705.5M 4.18B 2025-03
Sanofi 7.55B 118M 2024-12
Sarepta Therapeutics USD 156.1M 58.34M 2025-03
Takeda JPY 475.54B 15.36B 2025-03
Tectonic Therapeutic USD 976K 1.66M 2024-12
Ultragenyx Pharmaceutical USD 38.76M 2.77M 2024-12
Vertex Pharmaceuticals USD 413M 17.2M 2024-12
Xencor USD 16.19M 568K 2025-03



Alnylam Pharmaceuticals Créanciers Commerciaux - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.